Form 4: Guardant Health Director Acquires Shares via RSU Vesting
Insider Transaction Report
Guardant Health Director Musa Tariq acquired 250 shares of common stock through the vesting of restricted stock units.
Summary
- Musa Tariq, a Director at Guardant Health, Inc. (GH), acquired 250 shares of common stock.
- The acquisition occurred on October 15, 2025, through the vesting of restricted stock units (RSUs) at an exercise price of $0.
- Following this transaction, Musa Tariq beneficially owns 7,841 shares of common stock.
- The restricted stock unit award was originally granted on March 6, 2023, with a vesting schedule of 25% on March 15, 2024, and the remaining 75% vesting monthly over the subsequent three-year period.
- Musa Tariq continues to beneficially own 4,248 derivative securities (Restricted Stock Units) after this reported transaction.
Sentiment
Score: 6
Explanation: The filing reports a routine, scheduled insider transaction (RSU vesting). This is a neutral event for the company's operational performance but slightly positive for investor confidence as it shows continued director ownership and compensation realization.
Positives
- The vesting of restricted stock units increases the director's direct ownership in Guardant Health, aligning their interests further with shareholders.
- The transaction is a routine compensation event, indicating the company is fulfilling its obligations to its directors.
Industry Context
This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape for Guardant Health, Inc.
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholders due to higher direct stock ownership.
- Employees: Reflects standard compensation practices for company leadership.
Next Steps
- Remaining 4,248 restricted stock units will continue to vest monthly over the remaining period of the three-year schedule, following the initial 25% vesting.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date of original restricted stock unit award grant. |
| 03/15/2023 | Reference date for the start of the RSU vesting period. |
| 03/15/2024 | Date when 25% of the restricted stock unit award vested. |
| 10/15/2025 | Date of the reported transaction (vesting and acquisition of common stock). |
| 10/16/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Guardant Health, GH, Musa Tariq, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Stock Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.